Continuous Glucose Monitoring Systems
Continuous Glucose Monitoring Systems Market by Component (Receivers, Sensors, Transmitters), End User (Homecare Settings, Hospitals and Clinics, Research Institutes), Product Type, Application, Patient Demographics, Technology, Distribution Channel - Global Forecast 2025-2030
SKU
MRR-43676CF422F8
Region
Global
Publication Date
February 2025
Delivery
Immediate
2024
USD 6.21 billion
2025
USD 6.99 billion
2030
USD 12.56 billion
CAGR
12.45%

The Continuous Glucose Monitoring Systems Market size was estimated at USD 6.21 billion in 2024 and expected to reach USD 6.99 billion in 2025, at a CAGR 12.45% to reach USD 12.56 billion by 2030.

Continuous Glucose Monitoring Systems Market
To learn more about this report, request a free PDF copy

Continuous Glucose Monitoring (CGM) Systems have become an essential tool for managing diabetes by providing real-time glucose level data, which facilitates better glycemic control and reduces the need for frequent finger pricking. These systems are crucial for both Type 1 and Type 2 diabetes management, offering personalized insights into glucose fluctuations and aiding in effective decision-making regarding diet, exercise, and medication. The application scope of CGM spans personal use, where patients integrate these systems into their daily routines, to clinical settings where healthcare providers leverage CGM data for comprehensive diabetes management programs. In terms of end-use, major markets include individual patients, hospitals, and specialized diabetes care centers.

The growing prevalence of diabetes, increasing awareness about advanced diabetes management technologies, and favorable reimbursement policies are key growth influencers for the CGM market. Technological advancements like integration with smart devices and the development of non-invasive monitors present significant opportunities. Companies can capitalize on these by investing in R&D for continuous innovation, particularly in enhancing device accuracy and usability. The rise in telemedicine also opens avenues for remote diabetes monitoring, fostering innovations in user-friendly interfaces and data sharing capabilities.

However, the market faces challenges such as high costs, which can deter widespread adoption, particularly in developing regions. Regulatory hurdles and the need for standardized protocols further complicate market expansion. Addressing these challenges requires strategic partnerships and collaborations to streamline product offerings and ensure affordability. Moreover, continuous product iterations focused on reducing device size, increasing sensor longevity, and improving integration with holistic health platforms will spur market penetration. Innovation should also focus on enhancing data analytics capabilities, providing actionable insights for both users and healthcare providers. Understanding user experience and compliance challenges is crucial for designing next-generation CGM systems that cater to diverse consumer needs. As the market evolves, businesses should adopt agile strategies to swiftly adapt to technological and regulatory changes, ensuring sustained growth.

Ask ResearchAI anything

World's First Innovative Al for Market Research

Ask your question about the Continuous Glucose Monitoring Systems market, and ResearchAI will deliver precise answers.
How ResearchAI Enhances the Value of Your Research
ResearchAI-as-a-Service
Gain reliable, real-time access to a responsible AI platform tailored to meet all your research requirements.
24/7/365 Accessibility
Receive quick answers anytime, anywhere, so you’re always informed.
Maximize Research Value
Gain credits to improve your findings, complemented by comprehensive post-sales support.
Multi Language Support
Use the platform in your preferred language for a more comfortable experience.
Stay Competitive
Use AI insights to boost decision-making and join the research revolution at no extra cost.
Time and Effort Savings
Simplify your research process by reducing the waiting time for analyst interactions in traditional methods.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Continuous Glucose Monitoring Systems Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Essential market drivers shaping the continuous glucose monitoring systems industry landscape
    • Integral components fueling the continuous glucose monitoring systems market dynamics
    • Core influences propelling the widespread use of continuous glucose monitoring systems
  • Market Restraints
    • Challenges in adoption and cost barriers hindering the widespread use of glucose monitoring devices
    • Battery life and device reliability issues hampering the long-term acceptance of glucose monitoring systems
    • High product costs and reimbursement issues leading to limited accessibility in glucose monitoring systems
  • Market Opportunities
    • Enhancing user engagement with app-based solutions for real-time glucose monitoring insights
    • Meeting the needs of fitness enthusiasts and athletes with advanced glucose monitoring features
    • Utilizing AI and machine learning for enhanced analytics in continuous glucose monitoring solutions
  • Market Challenges
    • User adherence and acceptance are critical challenges facing glucose monitoring system adoption
    • Inadequate insurance coverage poses a significant barrier for market expansion of monitoring systems
    • The continuous glucose monitoring systems market faces challenges in high manufacturing costs

Market Segmentation Analysis

  • Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring

    Integrated insulin pumps are devices that deliver insulin automatically based on the set basal rate and work in conjunction with continuous glucose monitoring (CGM) systems. They adjust the insulin delivery based on real-time glucose readings. This feature greatly contributes to the seamless management of blood glucose levels in diabetes patients, especially useful for those with intensive insulin therapy needs or those with Type 1 diabetes. Sensors are a crucial part of CGM systems, as they are the components that measure levels of glucose in the interstitial fluid beneath the skin. CGM sensors typically require changing every 7 to 14 days, depending on the model. Patients who desire minimal intrusion and longer wear times prefer sensors with extended life spans. The transmitter is the part of the CGM system that sends real-time glucose data from the sensor to a receiver and smart device. The receiver is the device that displays the glucose data. Some patients prioritize a system that allows the use of their own smartphone as a receiver, whereas others prefer a dedicated device if they are not comfortable using smart devices.

  • Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive

    Continuous Glucose Monitoring (CGM) systems are crucial for the adult population, especially those diagnosed with Type 1 or Type 2 diabetes. Adults require consistent and accurate monitoring of their blood glucose levels to manage their condition effectively and to prevent acute and long-term complications associated with diabetes. CGM systems for children are designed with special considerations for size, sensitivity, and ease of use, owing to the unique physiological and lifestyle requirements of the pediatric population. These devices help parents and caregivers monitor and manage their child's diabetes more effectively, providing peace of mind and improved quality of life.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Continuous Glucose Monitoring Systems Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

PESTLE Analysis

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Continuous Glucose Monitoring Systems Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Continuous Glucose Monitoring Systems Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Continuous Glucose Monitoring Systems Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Recent Developments

  • Sibionics obtains CE Mark for GS1 continuous glucose monitoring system

    Sibionics, a Chinese medical technology startup, has received the CE Mark for its pioneering GS1 Continuous Glucose Monitoring (CGM) system, signaling the green light for the system's sale and usage across the European market. This certification confirms the GS1 CGM's compliance with stringent EU standards for quality, safety, and performance, which are essential for consumer trust. [Published On: November 02, 2023]

  • Dexcom targets Americans with new CGM aimed at non-insulin-using diabetics

    Dexcom is set to revolutionize the continuous glucose monitoring (CGM) market by unveiling a new device tailored for Americans living with Type 2 diabetes who do not require insulin therapy. This strategic move addresses a critical gap, highlighted by Dexcom's research, which is that a mere 5% of this demographic currently utilizes CGM technology. [Published On: June 26, 2023]

  • U.S. FDA Clears Abbott's Freestyle Libre 2 and Freestyle Libre 3 Sensors for Integration with Automated Insulin Delivery Systems

    Abbott has announced FDA clearance for its next-generation FreeStyle Libre 2 and FreeStyle Libre 3 iCGM sensors, paving the way for their seamless integration with automated insulin delivery (AID) systems. Expanding their versatility, the improved sensors offer additional convenience and support for diabetes management by pairing them with insulin pumps to adjust insulin delivery automatically based on continuously monitored glucose levels. [Published On: March 06, 2023]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Continuous Glucose Monitoring Systems Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Continuous Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, Abbott Laboratories, AgaMatrix Inc. by I-Sens Inc., Ascensia Diabetes Care Holdings AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, NXP Semiconductors N.V., Senseonics Holdings Inc., Sibionics, STMicroelectronics N.V., Tandem Diabetes Care, Inc., Texas Instruments Incorporated, and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Continuous Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Receivers
      • Connected Receivers
      • Handheld Receivers
    • Sensors
      • Disposable Sensors
      • Non-Disposable Sensors
    • Transmitters
      • Non-Rechargeable Transmitters
      • Rechargeable Transmitters
  • End User
    • Homecare Settings
      • Family-Assisted Monitoring
      • Self-Monitoring
    • Hospitals and Clinics
      • Inpatient Monitoring
      • Outpatient Monitoring
    • Research Institutes
      • Academic Research
      • Clinical Trials
  • Product Type
    • Integrated Systems
      • With Insulin Pumps
      • With Smartphone Integration
    • Standalone Systems
      • Advanced Standalone Systems
      • Basic Standalone Systems
  • Application
    • Gestational Diabetes
      • Preexisting Diabetes
      • Pregnancy-Induced Diabetes
    • Type 1 Diabetes
      • Adult Type 1 Diabetes
      • Pediatric Type 1 Diabetes
    • Type 2 Diabetes
      • With Insulin Therapy
      • Without Insulin Therapy
  • Patient Demographics
    • Age Group
      • Adolescents
      • Adults
      • Children
      • Elderly
    • Gender
      • Female
      • Male
    • Health Condition
      • With Comorbid Conditions
      • Without Comorbid Conditions
  • Technology
    • Non-Invasive Technologies
      • Electromagnetic Techniques
      • Optical Detection Methods
    • Wearable Technology
      • Adhesive Wearables
      • Non-Adhesive Wearables
  • Distribution Channel
    • Online Sales
      • Manufacturers' Websites
      • Third-Party Websites
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Continuous Glucose Monitoring Systems Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Continuous Glucose Monitoring Systems Market, by Component
  7. Continuous Glucose Monitoring Systems Market, by End User
  8. Continuous Glucose Monitoring Systems Market, by Product Type
  9. Continuous Glucose Monitoring Systems Market, by Application
  10. Continuous Glucose Monitoring Systems Market, by Patient Demographics
  11. Continuous Glucose Monitoring Systems Market, by Technology
  12. Continuous Glucose Monitoring Systems Market, by Distribution Channel
  13. Americas Continuous Glucose Monitoring Systems Market
  14. Asia-Pacific Continuous Glucose Monitoring Systems Market
  15. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market
  16. Competitive Landscape
  17. List of Figures [Total: 31]
  18. List of Tables [Total: 1118 ]
  19. List of Companies Mentioned [Total: 19]
360iResearch Analyst Ketan Rohom
Download a Free PDF
Get a sneak peek into the valuable insights and in-depth analysis featured in our comprehensive continuous glucose monitoring systems market report. Download now to stay ahead in the industry! Need more tailored information? Ketan is here to help you find exactly what you need.
Frequently Asked Questions
  1. How big is the Continuous Glucose Monitoring Systems Market?
    Ans. The Global Continuous Glucose Monitoring Systems Market size was estimated at USD 6.21 billion in 2024 and expected to reach USD 6.99 billion in 2025.
  2. What is the Continuous Glucose Monitoring Systems Market growth?
    Ans. The Global Continuous Glucose Monitoring Systems Market to grow USD 12.56 billion by 2030, at a CAGR of 12.45%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.